4598 — Delta-Fly Pharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapMomentum Trap

Annual balance sheet for Delta-Fly Pharma, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	—	—	—	—	—
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	JAS	JAS	JAS	JAS	JAS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	2,089	1,268	844	1,417	339
Net Total Receivables	—	—	—	—	51.5
Prepaid Expenses
Total Other Current Assets
Total Current Assets	2,115	1,281	866	1,433	395
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	41.6	39.9	38.6	38.2	36.8
Net Intangible Assets
Other Long Term Assets
Total Assets	2,161	1,324	907	1,474	434
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	82.5	91.2	116	241	157
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	82.5	91.2	116	241	157
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	2,079	1,233	791	1,233	278
Total Liabilities & Shareholders' Equity	2,161	1,324	907	1,474	434
Total Common Shares Outstanding